Article
Epigenetic mechanisms underlying prostate cancer radioresistance
8 Jun 2021
Abstract excerpt
Radiotherapy (RT) is one of the mainstay treatments for prostate cancer (PCa), a highly prevalent neoplasm among males worldwide. About 30% of newly diagnosed PCa patients receive RT with a curative intent. However, biochemical relapse occurs in 20-40% of advanced PCa treated with RT either alone or in combination with adjuvant-hormonal therapy. Epigenetic alterations, frequently associated with molecular...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
